<doc:document xmlns:doc="http://www.elsevier.com/xml/document/schema" xmlns:dp="http://www.elsevier.com/xml/common/doc-properties/schema" xmlns:cps="http://www.elsevier.com/xml/common/consyn-properties/schema" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dct="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:oa="http://vtw.elsevier.com/data/ns/properties/OpenAccess-1/" xmlns:bam="http://vtw.elsevier.com/data/voc/ns/bam-vtw-1/" xmlns:cp="http://vtw.elsevier.com/data/ns/properties/Copyright-1/" xmlns:cja="http://www.elsevier.com/xml/cja/schema" xmlns:ja="http://www.elsevier.com/xml/ja/schema" xmlns:bk="http://www.elsevier.com/xml/bk/schema" xmlns:ce="http://www.elsevier.com/xml/common/schema" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:cals="http://www.elsevier.com/xml/common/cals/schema" xmlns:tb="http://www.elsevier.com/xml/common/table/schema" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/schema" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/schema" xmlns:xlink="http://www.w3.org/1999/xlink"><rdf:RDF><rdf:Description rdf:about="http://dx.doi.org/10.1016/j.phyplu.2021.100152"><dct:format>application/xml</dct:format><dct:title>Demethylbellidifolin, a potential aldose reductase inhibitor ameliorates diabetic nephropathy by regulating the polyol pathway</dct:title><dct:creator>Haifei Xie</dct:creator><dct:creator>Qilin Tong</dct:creator><dct:creator>Zhinan Xiang</dct:creator><dct:creator>Chenggao Zhou</dct:creator><dct:creator>Luo-Sheng Wan</dct:creator><dct:creator>Jiachun Chen</dct:creator><dct:subject><rdf:Bag><rdf:li>Swertia</rdf:li><rdf:li>Diabetic nephropathy</rdf:li><rdf:li>Aldose reductase</rdf:li><rdf:li>Db/db mice</rdf:li><rdf:li>Polyol pathway</rdf:li></rdf:Bag></dct:subject><dct:description>Phytomedicine Plus 2 (2022). doi:10.1016/j.phyplu.2021.100152</dct:description><prism:aggregationType>journal</prism:aggregationType><prism:publicationName>Phytomedicine Plus</prism:publicationName><prism:copyright>&#169; 2021 The Author(s). Published by Elsevier B.V.</prism:copyright><dct:publisher>Elsevier B.V.</dct:publisher><prism:issn>2667-0313</prism:issn><prism:volume>2</prism:volume><prism:number>1</prism:number><prism:coverDisplayDate>February 2022</prism:coverDisplayDate><prism:doi>10.1016/j.phyplu.2021.100152</prism:doi><prism:url>http://dx.doi.org/10.1016/j.phyplu.2021.100152</prism:url><dct:identifier>doi:10.1016/j.phyplu.2021.100152</dct:identifier><bam:articleNumber>100152</bam:articleNumber><oa:openAccessInformation><oa:openAccessStatus xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://vtw.elsevier.com/data/voc/oa/OpenAccessStatus#Full</oa:openAccessStatus><oa:openAccessEffective xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">2021-10-29T13:46:55Z</oa:openAccessEffective><oa:sponsor xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><oa:sponsorName>China Institutes Tracking agreement</oa:sponsorName><oa:sponsorType>http://vtw.elsevier.com/data/voc/oa/SponsorType#Author</oa:sponsorType></oa:sponsor><oa:userLicense xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://creativecommons.org/licenses/by-nc-nd/4.0/</oa:userLicense></oa:openAccessInformation><cp:licenseLine xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">This is an open access article under the CC BY-NC-ND license.</cp:licenseLine></rdf:Description></rdf:RDF><dp:document-properties><dp:aggregation-type>Journals</dp:aggregation-type><dp:version-number>S300.1</dp:version-number></dp:document-properties><ja:article docsubtype="fla" version="5.6" xml:lang="en"><ja:item-info><ja:jid>PHYPLU</ja:jid><ja:aid>100152</ja:aid><ce:article-number>100152</ce:article-number><ce:pii>S2667-0313(21)00134-2</ce:pii><ce:doi>10.1016/j.phyplu.2021.100152</ce:doi><ce:copyright type="other" year="2021">The Author(s)</ce:copyright></ja:item-info><ja:head><ce:title id="tte0002">Demethylbellidifolin, a potential aldose reductase inhibitor ameliorates diabetic nephropathy by regulating the polyol pathway</ce:title><ce:author-group id="aut0001"><ce:author id="au0001" author-id="S2667031321001342-8aff54ca4a1f8b4489500c8b8e7111f9"><ce:given-name>Haifei</ce:given-name><ce:surname>Xie</ce:surname></ce:author><ce:author id="au0002" author-id="S2667031321001342-98c9fc57c5b177685f31b4f43160ddba"><ce:given-name>Qilin</ce:given-name><ce:surname>Tong</ce:surname></ce:author><ce:author id="au0003" author-id="S2667031321001342-88fbf25a7d8d2602ea25a2e8879a40d0"><ce:given-name>Zhinan</ce:given-name><ce:surname>Xiang</ce:surname></ce:author><ce:author id="au0004" author-id="S2667031321001342-5043d96aee68ce3d5812a2716f833e20"><ce:given-name>Chenggao</ce:given-name><ce:surname>Zhou</ce:surname></ce:author><ce:author id="au0005" author-id="S2667031321001342-9571739c5f0c3b1cecb12375c41fc45a"><ce:given-name>Luo-Sheng</ce:given-name><ce:surname>Wan</ce:surname><ce:cross-ref refid="cor0001"><ce:sup loc="post">&#x204e;</ce:sup></ce:cross-ref><ce:e-address type="email" xlink:href="mailto:wanluosheng@hust.edu.cn" id="ead0001">wanluosheng@hust.edu.cn</ce:e-address></ce:author><ce:author id="au0006" author-id="S2667031321001342-064399ecbad4f790c2ffc25005189b2d"><ce:given-name>Jiachun</ce:given-name><ce:surname>Chen</ce:surname><ce:cross-ref refid="cor0001"><ce:sup loc="post">&#x204e;</ce:sup></ce:cross-ref><ce:e-address id="ead0002" type="email" xlink:href="mailto:homespringchen@126.com">homespringchen@126.com</ce:e-address></ce:author><ce:affiliation id="aff0001" affiliation-id="S2667031321001342-57b5da7c770e8f8af06f0818df100cb9"><ce:textfn id="cetextfn0001">Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, College of Pharmacy, Huazhong University of Science and Technology, Hangkong Road 13, Wuhan 430030, Hubei Province, China</ce:textfn><sa:affiliation><sa:organization>Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, College of Pharmacy</sa:organization><sa:organization>Huazhong University of Science and Technology</sa:organization><sa:address-line>Hangkong Road 13</sa:address-line><sa:city>Wuhan</sa:city><sa:state>Hubei Province</sa:state><sa:postal-code>430030</sa:postal-code><sa:country>China</sa:country></sa:affiliation><ce:source-text id="staff0001">Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, College of Pharmacy, Huazhong University of Science and Technology, Hangkong Road 13, Wuhan 430030, Hubei Province, China</ce:source-text></ce:affiliation><ce:correspondence id="cor0001"><ce:label>&#x204e;</ce:label><ce:text id="cetext0001">Corresponding authors at: Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, College of Pharmacy, Huazhong University of Science and Technology, Hangkong Road 13, Wuhan 430030, Hubei Province, China.</ce:text><sa:affiliation><sa:organization>Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, College of Pharmacy</sa:organization><sa:organization>Huazhong University of Science and Technology</sa:organization><sa:address-line>Hangkong Road 13</sa:address-line><sa:city>Wuhan</sa:city><sa:state>Hubei Province</sa:state><sa:postal-code>430030</sa:postal-code><sa:country>China</sa:country></sa:affiliation></ce:correspondence></ce:author-group><ce:date-received day="1" month="8" year="2021"/><ce:date-revised day="25" month="10" year="2021"/><ce:date-accepted day="29" month="10" year="2021"/><ce:abstract id="abs0001" view="all" class="author"><ce:section-title id="cesectitle0001">Abstract</ce:section-title><ce:abstract-sec id="abss0001" role="background" view="all"><ce:section-title id="cesectitle0002">Background</ce:section-title><ce:simple-para id="spara011" view="all">Lots of plants in genus <ce:italic>Swertia</ce:italic> are widely used in the traditional medicine as the treatment for T2DM and its complications in Asia. However, the pharmacodynamic material basis and underlying mechanisms of these plants are still incompletely studied. Inhibition of aldose reductase to regulate polyol pathway is considered to be one effective strategy to treat many complications arising from diabetes.</ce:simple-para></ce:abstract-sec><ce:abstract-sec id="abss0002" view="all"><ce:section-title id="cesectitle0003">Aim</ce:section-title><ce:simple-para id="spara012" view="all">The inhibitory effect against aldose reductase of typical components from the genus <ce:italic>Swertia</ce:italic> were examined, and further verified in db/db mice model to explore its in vivo renal protective ability and underlying mechanism.</ce:simple-para></ce:abstract-sec><ce:abstract-sec id="abss0003" role="materials-methods" view="all"><ce:section-title id="cesectitle0004">Methods</ce:section-title><ce:simple-para id="spara013" view="all">Human recombinant aldose reductase (AR) was applied to detect the inhibitory activity of these components from genus <ce:italic>Swetia</ce:italic> in vitro, and the most active one was further analyzed in molecular docking experiment. Then, db/db diabetic mice model were employed to investigate the renal protective effects in vivo. Oxidative stress and renal function related indicators were determined using biochemical kit. Histopathological examination of kidney was conducted to evaluate pathological variations. RT-PCR was applied to measure the level of AR mRNA in renal cortex. Expression of AR, TGF-<ce:italic>&#x03b2;</ce:italic>1, Collagen &#x2163;, Nephrin and Podocin in kidney tissues were assessed by Western blot.</ce:simple-para></ce:abstract-sec><ce:abstract-sec id="abss0004" role="results" view="all"><ce:section-title id="cesectitle0005">Results</ce:section-title><ce:simple-para id="spara014" view="all">It turned out that demethylbellidifolin (DMB) showed the strongest inhibitory activity against AR, with an IC<ce:inf loc="post">50</ce:inf> of 1.29&#160;&#177;&#160;0.16&#160;<ce:italic>&#x03bc;</ce:italic>M, by stabilizing the active site of AR. In vivo experiment confirmed that DMB could remarkably reduce blood glucose and albuminuria level, and alleviate oxidative stress response. Meanwhile, histopathological examination also displayed that the kidney damage in db/db mice was significantly improved after treatment with DMB. Further mechanism study indicated that DMB could prevent the accumulation of sorbitol, one of the polyol pathway products. Besides, DMB could also maintaining the integrity of podocytes structure by up-regulating the expression of Nephrin and Podocin, and exert renal protective effects by inhibiting the expression of AR, Collagen &#x2163; and TGF-<ce:italic>&#x03b2;</ce:italic>1 in the polyol pathway.</ce:simple-para></ce:abstract-sec><ce:abstract-sec id="abss0005" role="conclusion" view="all"><ce:section-title id="cesectitle0006">Conclusions</ce:section-title><ce:simple-para id="spara015" view="all">These findings indicated that genus <ce:italic>Swertia</ce:italic> could be an important plant sources of aldose reductase inhibitors, and one of its typical components, DMB, exerted a therapeutic role in the treatment of diabetic nephropathy by regulating the polyol pathway to relieve the injury of cells in the kidney, and may represent a promising renal protective medication for diabetic nephropathy therapy.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:abstract id="abs0002" class="graphical" view="all"><ce:section-title id="cesectitle0007">Graphical abstract</ce:section-title><ce:abstract-sec id="abss0007" view="all"><ce:simple-para id="spara016" view="all"> [Display omitted] </ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords id="keys0001" view="all" class="keyword"><ce:section-title id="cesectitle0008">Keywords</ce:section-title><ce:keyword id="key0001"><ce:text id="cetext0002">Swertia</ce:text></ce:keyword><ce:keyword id="key0002"><ce:text id="cetext0003">Diabetic nephropathy</ce:text></ce:keyword><ce:keyword id="key0003"><ce:text id="cetext0004">Aldose reductase</ce:text></ce:keyword><ce:keyword id="key0004"><ce:text id="cetext0005">Db/db mice</ce:text></ce:keyword><ce:keyword id="key0005"><ce:text id="cetext0006">Polyol pathway</ce:text></ce:keyword></ce:keywords><ce:keywords id="keys0002" class="abr" view="all"><ce:section-title id="cesectitle0009">Abbreviations</ce:section-title><ce:keyword id="key0006"><ce:text id="cetext0007">Alb</ce:text><ce:keyword id="key7a"><ce:text id="cetext7a">micro Albuminuria</ce:text></ce:keyword></ce:keyword><ce:keyword id="key0007"><ce:text id="cetext0008">ARIs</ce:text><ce:keyword id="key8a"><ce:text id="cetext8a">Aldose reductase inhibitors</ce:text></ce:keyword></ce:keyword><ce:keyword id="key0008"><ce:text id="cetext0009">BUN</ce:text><ce:keyword id="key9a"><ce:text id="cetext9a">blood urea nitrogen</ce:text></ce:keyword></ce:keyword><ce:keyword id="key0009"><ce:text id="cetext0010">BW</ce:text><ce:keyword id="key10a"><ce:text id="cetext10a">body weight</ce:text></ce:keyword></ce:keyword><ce:keyword id="key0010"><ce:text id="cetext0011">DN</ce:text><ce:keyword id="key11a"><ce:text id="cetext11a">diabetic nephropathy</ce:text></ce:keyword></ce:keyword><ce:keyword id="key0011"><ce:text id="cetext0012">DMB</ce:text><ce:keyword id="key12a"><ce:text id="cetext12a">deme-thylbellidifolin</ce:text></ce:keyword></ce:keyword><ce:keyword id="key0012"><ce:text id="cetext0013">EPS</ce:text><ce:keyword id="key13a"><ce:text id="cetext13a">epalrestat</ce:text></ce:keyword></ce:keyword><ce:keyword id="key0013"><ce:text id="cetext0014">FBG</ce:text><ce:keyword id="key14a"><ce:text id="cetext14a">fasting blood glucose</ce:text></ce:keyword></ce:keyword><ce:keyword id="key0014"><ce:text id="cetext0015">HE</ce:text><ce:keyword id="key15a"><ce:text id="cetext15a">hematoxylin-eosin</ce:text></ce:keyword></ce:keyword><ce:keyword id="key0015"><ce:text id="cetext0016">MDA</ce:text><ce:keyword id="key16a"><ce:text id="cetext16a">malondialdehyde</ce:text></ce:keyword></ce:keyword><ce:keyword id="key0016"><ce:text id="cetext0017">NADPH</ce:text><ce:keyword id="key17a"><ce:text id="cetext17a">Nicotinamide adenine dinucleotide phosphate</ce:text></ce:keyword></ce:keyword><ce:keyword id="key0017"><ce:text id="cetext0018">PAS</ce:text><ce:keyword id="key18a"><ce:text id="cetext18a">periodic acid-schiff stain</ce:text></ce:keyword></ce:keyword><ce:keyword id="key0018"><ce:text id="cetext0019">RT-qPCR</ce:text><ce:keyword id="key19a"><ce:text id="cetext19a">Real-time quantitative polymerasechain reaction</ce:text></ce:keyword></ce:keyword><ce:keyword id="key0019"><ce:text id="cetext0020">Scr</ce:text><ce:keyword id="key20a"><ce:text id="cetext20a">serum creatinine</ce:text></ce:keyword></ce:keyword><ce:keyword id="key0020"><ce:text id="cetext0021">T-AOC</ce:text><ce:keyword id="key21a"><ce:text id="cetext21a">total antioxidant capacity</ce:text></ce:keyword></ce:keyword><ce:keyword id="key0021"><ce:text id="cetext0022">TGF-<ce:italic>&#x03b2;</ce:italic>1</ce:text><ce:keyword id="key22a"><ce:text id="cetext22a">trans-forming growth factor-<ce:italic>&#x03b2;</ce:italic></ce:text></ce:keyword></ce:keyword><ce:keyword id="key0022"><ce:text id="cetext0023">T-SOD</ce:text><ce:keyword id="key23a"><ce:text id="cetext23a">total superoxide dismutase</ce:text></ce:keyword></ce:keyword><ce:keyword id="key0023"><ce:text id="cetext0024">T2DM</ce:text><ce:keyword id="key24a"><ce:text id="cetext24a">type 2 diabetes mellitus</ce:text></ce:keyword></ce:keyword><ce:keyword id="key0024"><ce:text id="cetext0025">Ucr</ce:text><ce:keyword id="key25a"><ce:text id="cetext25a">urine creatinine</ce:text></ce:keyword></ce:keyword></ce:keywords></ja:head></ja:article></doc:document>
